Search research articles
Contact Us
Filters
Showing results (1-10 of 59) with videos related to
Page
of 6
Sort By:
Current Topics in Microbiology and Immunology
|
September 22, 2009
Recombinant proteins produced in insect cells
John Treanor
Seminars in Respiratory and Critical Care Medicine
|
April 27, 2007
Pandemic (avian) influenza
Sumanth Rajagopal, John Treanor
Vaccine
|
March 5, 2003
Non-interference between two protein carriers when used with the same polysaccharide for pneumococcal conjugate vaccines in 2-year-old children
Porter Anderson, John Treanor, Susan Porcelli, et al.
Antiviral Therapy
|
January 25, 2006
Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: randomized, controlled trials for prophylaxis and treatment
Luis Barroso, John Treanor, Larisa Gubareva, et al.
Lancet (London, England)
|
December 14, 2002
Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study
Michael E Pichichero, Elsa Cernichiari, Joseph Lopreiato, et al.
Vaccine
|
October 4, 2006
Immune responses to vaccinia and influenza elicited during primary versus recent or distant secondary smallpox vaccination of adults
John Treanor, Hulin Wu, Hua Liang, et al.
Influenza and Other Respiratory Viruses
|
May 21, 2009
FluBlok, a recombinant hemagglutinin influenza vaccine
Manon M J Cox, Peter A Patriarca, John Treanor
Journal of Biopharmaceutical Statistics
|
May 26, 2017
Maximum Likelihood Estimation of Titer via a Power Family of Four-Parameter Logistic Model
Hongmei Yang, Jeanne Holden-Wiltse, David J Topham, et al.
The Pediatric Infectious Disease Journal
|
January 25, 2003
Effect of yearly vaccinations with live, attenuated, cold-adapted, trivalent, intranasal influenza vaccines on antibody responses in children
David I Bernstein, Lihan Yan, John Treanor, et al.
Human Vaccines
|
October 14, 2006
Phase I, randomized, controlled trial to study the reactogenicity and immunogenicity of a nasal, inactivated trivalent influenza virus vaccine in healthy adults
Scott A Halperin, Bruce Smith, Kevin Clarke, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 59) with videos related to
Sort By:
Page
of 6
Current Topics in Microbiology and Immunology
|
September 22, 2009
Recombinant proteins produced in insect cells
John Treanor
Seminars in Respiratory and Critical Care Medicine
|
April 27, 2007
Pandemic (avian) influenza
Sumanth Rajagopal, John Treanor
Vaccine
|
March 5, 2003
Non-interference between two protein carriers when used with the same polysaccharide for pneumococcal conjugate vaccines in 2-year-old children
Porter Anderson, John Treanor, Susan Porcelli, et al.
Antiviral Therapy
|
January 25, 2006
Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: randomized, controlled trials for prophylaxis and treatment
Luis Barroso, John Treanor, Larisa Gubareva, et al.
Lancet (London, England)
|
December 14, 2002
Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study
Michael E Pichichero, Elsa Cernichiari, Joseph Lopreiato, et al.
Vaccine
|
October 4, 2006
Immune responses to vaccinia and influenza elicited during primary versus recent or distant secondary smallpox vaccination of adults
John Treanor, Hulin Wu, Hua Liang, et al.
Influenza and Other Respiratory Viruses
|
May 21, 2009
FluBlok, a recombinant hemagglutinin influenza vaccine
Manon M J Cox, Peter A Patriarca, John Treanor
Journal of Biopharmaceutical Statistics
|
May 26, 2017
Maximum Likelihood Estimation of Titer via a Power Family of Four-Parameter Logistic Model
Hongmei Yang, Jeanne Holden-Wiltse, David J Topham, et al.
The Pediatric Infectious Disease Journal
|
January 25, 2003
Effect of yearly vaccinations with live, attenuated, cold-adapted, trivalent, intranasal influenza vaccines on antibody responses in children
David I Bernstein, Lihan Yan, John Treanor, et al.
Human Vaccines
|
October 14, 2006
Phase I, randomized, controlled trial to study the reactogenicity and immunogenicity of a nasal, inactivated trivalent influenza virus vaccine in healthy adults
Scott A Halperin, Bruce Smith, Kevin Clarke, et al.
Page
of 6